- Home
- MEGI vs FLGT Comparison
MEGI vs FLGT Comparison
Compare MEGI & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGI
- FLGT
- Stock Information
- Founded
- MEGI 2021
- FLGT 2011
- Country
- MEGI United States
- FLGT United States
- Employees
- MEGI N/A
- FLGT N/A
- Industry
- MEGI Investment Managers
- FLGT Medical Specialities
- Sector
- MEGI Finance
- FLGT Health Care
- Exchange
- MEGI Nasdaq
- FLGT Nasdaq
- Market Cap
- MEGI 774.5M
- FLGT 697.3M
- IPO Year
- MEGI N/A
- FLGT 2016
- Fundamental
- Price
- MEGI $14.06
- FLGT $29.49
- Analyst Decision
- MEGI
- FLGT Buy
- Analyst Count
- MEGI 0
- FLGT 3
- Target Price
- MEGI N/A
- FLGT $28.33
- AVG Volume (30 Days)
- MEGI 178.0K
- FLGT 332.6K
- Earning Date
- MEGI 01-01-0001
- FLGT 11-07-2025
- Dividend Yield
- MEGI 11.40%
- FLGT N/A
- EPS Growth
- MEGI N/A
- FLGT N/A
- EPS
- MEGI N/A
- FLGT N/A
- Revenue
- MEGI N/A
- FLGT $315,549,000.00
- Revenue This Year
- MEGI N/A
- FLGT $15.19
- Revenue Next Year
- MEGI N/A
- FLGT $10.58
- P/E Ratio
- MEGI N/A
- FLGT N/A
- Revenue Growth
- MEGI N/A
- FLGT 13.61
- 52 Week Low
- MEGI $10.63
- FLGT $14.57
- 52 Week High
- MEGI $14.89
- FLGT $30.59
- Technical
- Relative Strength Index (RSI)
- MEGI 36.44
- FLGT 81.41
- Support Level
- MEGI $13.93
- FLGT $22.12
- Resistance Level
- MEGI $14.28
- FLGT $23.15
- Average True Range (ATR)
- MEGI 0.21
- FLGT 1.11
- MACD
- MEGI -0.02
- FLGT 0.69
- Stochastic Oscillator
- MEGI 13.10
- FLGT 86.75
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.